Loading...

Omaxe

NSEI:OMAXE
Snowflake Description

Imperfect balance sheet with concerning outlook.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OMAXE
NSEI
₹38B
Market Cap
  1. Home
  2. IN
  3. Real Estate
Company description

Omaxe Limited operates as a real estate development company in India. The last earnings update was 71 days ago. More info.


Add to Portfolio Compare Print
OMAXE Share Price and Events
7 Day Returns
-0.6%
NSEI:OMAXE
-5%
IN Real Estate
-1.9%
IN Market
1 Year Returns
-3.7%
NSEI:OMAXE
-17.3%
IN Real Estate
-2.8%
IN Market
OMAXE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Omaxe (OMAXE) -0.6% 1.7% -1.2% -3.7% 43.9% 65%
IN Real Estate -5% -2.9% 7.6% -17.3% 48.6% 46.5%
IN Market -1.9% 1.2% 5.1% -2.8% 38.3% 71%
1 Year Return vs Industry and Market
  • OMAXE outperformed the Real Estate industry which returned -17.3% over the past year.
Price Volatility
OMAXE
Industry
5yr Volatility vs Market
Related Companies

OMAXE Value

 Is Omaxe undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Omaxe to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Omaxe.

NSEI:OMAXE Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 18.2%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NSEI:OMAXE
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Real Estate Unlevered Beta Simply Wall St/ S&P Global 1.1
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.102 (1 + (1- 35%) (36.53%))
1.244
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.24
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (1.244 * 8.6%)
18.25%

Discounted Cash Flow Calculation for NSEI:OMAXE using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Omaxe is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NSEI:OMAXE DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 18.25%)
2019 276.63 Est @ 7.14% 233.94
2020 296.72 Est @ 7.26% 212.20
2021 318.52 Est @ 7.35% 192.65
2022 342.12 Est @ 7.41% 174.99
2023 367.61 Est @ 7.45% 159.01
2024 395.12 Est @ 7.48% 144.53
2025 424.76 Est @ 7.5% 131.40
2026 456.68 Est @ 7.52% 119.47
2027 491.05 Est @ 7.53% 108.64
2028 528.05 Est @ 7.53% 98.80
Present value of next 10 years cash flows ₹1,575.62
NSEI:OMAXE DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₹528.05 × (1 + 7.55%) ÷ (18.25% – 7.55%)
₹5,308.65
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹5,308.65 ÷ (1 + 18.25%)10
₹993.23
NSEI:OMAXE Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹1,575.62 + ₹993.23
₹2,568.85
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹2,568.85 / 182.90
₹14.05
NSEI:OMAXE Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in NSEI:OMAXE represents 0.99976x of BSE:532880
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99976x
Value per Share
(Listing Adjusted, INR)
= Value per Share (INR) x Listing Adjustment Factor
= ₹ 14.05 x 0.99976
₹14.04
Value per share (INR) From above. ₹14.04
Current discount Discount to share price of ₹210.45
= -1 x (₹210.45 - ₹14.04) / ₹14.04
-1398.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Omaxe is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Omaxe's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Omaxe's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:OMAXE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in INR ₹2.80
BSE:532880 Share Price ** BSE (2019-04-24) in INR ₹210.5
India Real Estate Industry PE Ratio Median Figure of 105 Publicly-Listed Real Estate Companies 16.58x
India Market PE Ratio Median Figure of 2,739 Publicly-Listed Companies 16.02x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Omaxe.

NSEI:OMAXE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:532880 Share Price ÷ EPS (both in INR)

= 210.5 ÷ 2.80

75.13x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Omaxe is overvalued based on earnings compared to the IN Real Estate industry average.
  • Omaxe is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Omaxe's expected growth come at a high price?
Raw Data
NSEI:OMAXE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 75.13x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
9.8%per year
India Real Estate Industry PEG Ratio Median Figure of 12 Publicly-Listed Real Estate Companies 1.31x
India Market PEG Ratio Median Figure of 586 Publicly-Listed Companies 1.32x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Omaxe, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Omaxe's assets?
Raw Data
NSEI:OMAXE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in INR ₹93.05
BSE:532880 Share Price * BSE (2019-04-24) in INR ₹210.5
India Real Estate Industry PB Ratio Median Figure of 164 Publicly-Listed Real Estate Companies 0.8x
India Market PB Ratio Median Figure of 3,630 Publicly-Listed Companies 1.09x
NSEI:OMAXE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:532880 Share Price ÷ Book Value per Share (both in INR)

= 210.5 ÷ 93.05

2.26x

* Primary Listing of Omaxe.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Omaxe is overvalued based on assets compared to the IN Real Estate industry average.
X
Value checks
We assess Omaxe's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Real Estate industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Real Estate industry average (and greater than 0)? (1 check)
  5. Omaxe has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

OMAXE Future Performance

 How is Omaxe expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Omaxe, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Omaxe expected to grow at an attractive rate?
  • Omaxe's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Omaxe's earnings growth is positive but not above the India market average.
  • Unable to compare Omaxe's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NSEI:OMAXE Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:OMAXE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 9.8%
India Real Estate Industry Earnings Growth Rate Market Cap Weighted Average 20.5%
India Real Estate Industry Revenue Growth Rate Market Cap Weighted Average 7%
India Market Earnings Growth Rate Market Cap Weighted Average 18.3%
India Market Revenue Growth Rate Market Cap Weighted Average 11.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:OMAXE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:OMAXE Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-12-31 13,580 513
2018-09-30 16,226 623
2018-06-30 15,301 697
2018-03-31 18,391 191 840
2017-12-31 18,003 736
2017-09-30 17,042 744
2017-06-30 16,718 798
2017-03-31 16,268 1,209 1,021
2016-12-31 18,330 1,191
2016-09-30 18,213 1,174
2016-06-30 17,955 1,060
2016-03-31 13,857 908 767

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Omaxe's earnings are expected to grow by 9.8% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Omaxe is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:OMAXE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Omaxe Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:OMAXE Past Financials Data
Date (Data in INR Millions) EPS *
2018-12-31 2.80
2018-09-30 3.43
2018-06-30 3.80
2018-03-31 4.59
2017-12-31 4.06
2017-09-30 4.07
2017-06-30 4.36
2017-03-31 5.58
2016-12-31 6.53
2016-09-30 6.38
2016-06-30 5.81
2016-03-31 4.20

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Omaxe will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Omaxe's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Omaxe has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

OMAXE Past Performance

  How has Omaxe performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Omaxe's growth in the last year to its industry (Real Estate).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Omaxe's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Omaxe's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Omaxe's 1-year earnings growth is negative, it can't be compared to the IN Real Estate industry average.
Earnings and Revenue History
Omaxe's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Omaxe Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:OMAXE Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 13,579.64 512.78 868.79
2018-09-30 16,225.64 622.78 830.89
2018-06-30 15,301.44 696.68 806.29
2018-03-31 18,390.94 839.98 796.29
2017-12-31 18,003.18 736.03 800.50
2017-09-30 17,041.73 743.54 802.42
2017-06-30 16,718.23 798.23 769.35
2017-03-31 16,267.53 1,020.88 750.64
2016-12-31 18,329.98 1,190.52 846.06
2016-09-30 18,213.13 1,173.86 835.74
2016-06-30 17,955.23 1,060.23 845.03
2016-03-31 13,857.25 767.47 870.73
2015-12-31 16,013.11 739.12 1,557.34
2015-09-30 14,676.03 701.46 1,553.58
2015-06-30 14,357.83 648.68 588.37
2015-03-31 14,310.85 597.67 826.57
2014-12-31 15,310.42 648.76 1,937.86
2014-09-30 15,660.75 672.05 1,917.60
2014-06-30 15,528.05 715.11 674.34
2014-03-31 16,231.25 784.84 1,977.98
2013-12-31 17,911.00 890.97 2,098.12
2013-09-30 20,150.20 1,017.01 2,131.41
2013-06-30 21,111.19 1,065.35 702.05
2013-03-31 20,775.43 1,056.79 2,077.28
2012-12-31 19,961.62 937.46 1,196.24
2012-09-30 18,860.42 842.11 1,168.89
2012-06-30 18,834.38 885.31 1,129.88

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Omaxe has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Omaxe used its assets less efficiently than the IN Real Estate industry average last year based on Return on Assets.
  • Omaxe's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Omaxe's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Real Estate industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Omaxe has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

OMAXE Health

 How is Omaxe's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Omaxe's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Omaxe is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Omaxe's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Omaxe's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 6.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Omaxe Company Filings, last reported 3 months ago.

NSEI:OMAXE Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 17,269.30 14,050.60 5,240.00
2018-09-30 17,269.30 14,050.60 5,240.00
2018-06-30 22,129.15 18,035.04 905.57
2018-03-31 22,129.15 18,035.04 905.57
2017-12-31 21,740.11 10,586.53 6,308.51
2017-09-30 21,740.11 10,586.53 6,308.51
2017-06-30 21,335.33 15,290.17 862.60
2017-03-31 21,335.33 15,054.02 862.60
2016-12-31 21,075.01 9,138.99 7,841.27
2016-09-30 21,075.01 9,138.99 7,841.27
2016-06-30 22,996.45 13,160.38 2,356.46
2016-03-31 20,424.15 13,434.27 1,186.49
2015-12-31 22,735.23 8,196.39 3,714.37
2015-09-30 22,735.23 8,196.39 3,714.37
2015-06-30 22,359.61 6,769.76 2,405.10
2015-03-31 22,359.62 11,066.33 2,405.10
2014-12-31 22,137.22 6,389.44 2,145.53
2014-09-30 22,137.22 6,389.44 2,145.53
2014-06-30 21,789.54 6,475.31 2,432.52
2014-03-31 21,789.54 10,653.21 2,432.53
2013-12-31 18,994.71 8,105.51 1,933.82
2013-09-30 18,994.71 8,105.51 1,933.82
2013-06-30 18,588.56 6,890.84 2,465.82
2013-03-31 18,588.56 11,076.29 2,465.82
2012-12-31 18,122.03 6,057.94 1,639.46
2012-09-30 18,122.03 6,057.94 1,639.46
2012-06-30 17,706.52 11,460.23 1,960.74
  • Omaxe's level of debt (81.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (42.8% vs 81.4% today).
  • Debt is not well covered by operating cash flow (1.4%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.5x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Omaxe's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Omaxe has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

OMAXE Dividends

 What is Omaxe's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.33%
Current annual income from Omaxe dividends.
If you bought ₹2,000 of Omaxe shares you are expected to receive ₹7 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Omaxe's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.51%).
  • Omaxe's dividend is below the markets top 25% of dividend payers in India (1.95%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:OMAXE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Real Estate Industry Average Dividend Yield Market Cap Weighted Average of 41 Stocks 0.8%
India Market Average Dividend Yield Market Cap Weighted Average of 1400 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.5%
India Top 25% Dividend Yield 75th Percentile 2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:OMAXE Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2018-07-25 0.700 0.327
2018-05-23 0.700 0.316
2017-07-31 0.700 0.326
2017-05-29 0.700 0.345
2017-03-31 0.700 0.367
2016-10-03 0.700 0.425
2015-10-01 0.500 0.343
2014-09-29 0.500 0.381
2013-08-27 0.700 0.557
2013-05-30 0.700 0.625
2010-05-27 0.000 0.000
2009-12-31 0.000 0.000
2009-11-03 0.000 0.000
2009-07-31 0.000 0.000
2009-06-30 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Omaxe has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Omaxe has only been paying a dividend for 6 years, and since then there has been no growth.
Current Payout to shareholders
What portion of Omaxe's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (4x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Omaxe's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Omaxe afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Omaxe has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

OMAXE Management

 What is the CEO of Omaxe's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mohit Goel
COMPENSATION ₹1,650,000
AGE 29
TENURE AS CEO 1.2 years
CEO Bio

Mr. Mohit Goel is Chief Executive Officer at Omaxe Limited since rejoining in February 12, 2018. He served as the Chief Executive Officer of Omaxe Ltd. (The Omaxe Group) until May 28, 2017. He worked at Omaxe since September 2010 to May 2017. Mr. Goel co-founded Supplified Technologies Private Limited in 2014. He has all the genes of an entrepreneur. He is able, young and aggressive. He is a stickler for routine and meticulous in his work. .During his tenure as the Head of Youth CREDAI (North Zone) – illustrious body of real estate developers, from April, 2013 to March, 2015, Mr. Mohit Goel was credited with galvanizing the institution and stimulating industry leaders and influencers. Displaying his leadership skills at the industry forum, Mr. Goel has been credited with infusing new energy in the institution through regular meetings, discussions, events etc. He has been a Director of Supplified Technologies Private Limited since July 13, 2015. He has 7 years of rich experience in Real Estate /Infrastructure in the areas of strategic & tactical planning, profit centre operations, marketing strategy and project management. Mr. Goel has also won the Young Achiever’s Award by ABP’s Real Estate Awards in 2014 along with the Young Male Entrepreneur of the Year Award by Infra & Realty Sutra Award 2014. Mr. Mohit Goel is a Commerce graduate, has attended Summer School at London School of Economics and has also done executive program from IIM, Bangalore.

CEO Compensation
  • Mohit's compensation has been consistent with company performance over the past year.
  • Mohit's remuneration is lower than average for companies of similar size in India.
Management Team Tenure

Average tenure and age of the Omaxe management team in years:

3.2
Average Tenure
47
Average Age
  • The tenure for the Omaxe management team is about average.
Management Team

Rohtas Goel

TITLE
Chairman & Managing Director
COMPENSATION
₹18M
AGE
56
TENURE
32.3 yrs

Mohit Goel

TITLE
Chief Executive Officer
COMPENSATION
₹2M
AGE
29
TENURE
1.2 yrs

Daleep Moudgil

TITLE
President
AGE
58

Bhupendra Singh

TITLE
President
AGE
47

Rajeev Goel

TITLE
President
AGE
55

Avneet Soni

TITLE
President
AGE
44

Surendra Goyal

TITLE
President
AGE
39

Vimal Gupta

TITLE
Vice President of Accounts & CFO
COMPENSATION
₹4M
AGE
49

Sudhangshu Biswal

TITLE
Whole Time Director
COMPENSATION
₹5M
AGE
47
TENURE
3.8 yrs

Shubha Singh

TITLE
VP of Legal
COMPENSATION
₹3M
TENURE
2.7 yrs
Board of Directors Tenure

Average tenure and age of the Omaxe board of directors in years:

2.7
Average Tenure
50.5
Average Age
  • The average tenure for the Omaxe board of directors is less than 3 years, this suggests a new board.
Board of Directors

Rohtas Goel

TITLE
Chairman & Managing Director
COMPENSATION
₹18M
AGE
56
TENURE
14 yrs

Sudhangshu Biswal

TITLE
Whole Time Director
COMPENSATION
₹5M
AGE
47
TENURE
2.7 yrs

Sudip Bandyopadhyay

TITLE
Independent Director
COMPENSATION
₹1M
AGE
54
TENURE
3.4 yrs

Seema Avasarala

TITLE
Non-Independent Woman Director
COMPENSATION
₹360K
AGE
42
TENURE
1.6 yrs

Gurnam Singh

TITLE
Non-Executive Independent Director
TENURE
0.2 yrs

Seema Salwan

TITLE
Non Executive Independent Director
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
27. Sep 18 Sell Nakul Goel Individual 24. Sep 18 25. Sep 18 -231,000 ₹217.60 ₹-50,219,644
07. Sep 18 Buy Sushma Goel Individual 01. Sep 18 01. Sep 18 1,898,450 ₹10.00 ₹18,984,436
09. Jul 18 Sell Nakul Goel Individual 04. Jul 18 05. Jul 18 -250,000 ₹216.93 ₹-53,996,605
09. Jul 18 Sell Nakul Goel Individual 04. Jul 18 05. Jul 18 -240,000 ₹216.93 ₹-51,840,706
05. Jul 18 Sell Nakul Goel Individual 02. Jul 18 02. Jul 18 -50,000 ₹217.56 ₹-10,871,794
05. Jul 18 Sell Nakul Goel Individual 02. Jul 18 02. Jul 18 -50,000 ₹217.56 ₹-10,871,790
31. May 18 Sell Rajeev Goel Individual 30. May 18 30. May 18 -3,173 ₹223.07 ₹-707,816
31. May 18 Sell Rajeev Goel Individual 30. May 18 30. May 18 -3,173 ₹223.07 ₹-707,815
X
Management checks
We assess Omaxe's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Omaxe has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

OMAXE News

Simply Wall St News

Who Has Been Selling Omaxe Limited (NSE:OMAXE) Shares?

So before you buy or sell Omaxe Limited (NSE:OMAXE), you may well want to know whether insiders have been buying or selling. … We generally tread carefully if insiders have been selling on market, even if they sold slightly above the current price. … In total, Omaxe insiders sold more than they bought over the last year.

Simply Wall St -

Should You Be Tempted To Sell Omaxe Limited (NSE:OMAXE) Because Of Its P/E Ratio?

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). … Omaxe has a price to earnings ratio of 73.39, based on the last twelve months. … How Do I Calculate Omaxe's Price To Earnings Ratio

Simply Wall St -

Can Omaxe Limited (NSE:OMAXE) Improve Its Returns?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … That means that for every ₹1 worth of shareholders' equity, it generated ₹0.035 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Was Omaxe Limited's (NSE:OMAXE) Earnings Decline Part Of A Broader Industry Downturn?

Understanding Omaxe Limited's (NSE:OMAXE) performance as a company requires examining more than earnings from one point in time. … Today I will take you through a basic sense check to gain perspective on how Omaxe is doing by evaluating its latest earnings with its longer term trend as well as its industry peers' performance over the same period. … Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 0.4%, indicating the rate at which OMAXE is growing has slowed down

Simply Wall St -

Omaxe Limited (NSE:OMAXE) Insiders Have Been Selling

Omaxe Insider Transactions Over The Last Year. … Over the last year, we can see that the biggest insider sale was by Nakul Goel for ₹54m worth of shares, at about ₹217 per share. … Over the last year we saw more insider selling of Omaxe shares, than buying.

Simply Wall St -

What Does Omaxe Limited's (NSE:OMAXE) P/E Ratio Tell You?

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). … Omaxe has a price to earnings ratio of 56.01, based on the last twelve months. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Simply Wall St -

Omaxe Limited (NSE:OMAXE): Did It Outperform The Industry?

In this commentary, I will examine Omaxe Limited's (NSE:OMAXE) latest earnings update (30 June 2018) and compare these figures against its performance over the past couple of years, as well as how the rest of the real estate industry performed. … View our latest analysis for Omaxe? … OMAXE's trailing twelve-month earnings (from 30 June 2018) of ₹696.68m has

Simply Wall St -

Is Omaxe Limited (NSE:OMAXE) A Financially Sound Company?

While small-cap stocks, such as Omaxe Limited (NSE:OMAXE) with its market cap of ₹41.11b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … Assessing first and foremost the financial health is. … Here are a few basic checks that are good enough to have a broad overview of the company’s financial strength.

Simply Wall St -

Should You Sell Omaxe Limited (NSE:OMAXE) At This PE Ratio?

The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want to begin learning the link between Omaxe Limited (NSE:OMAXE)’s fundamentals and stock market performance. … While this makes OMAXE appear like a stock to avoid or sell if you own it, you might change your mind after I explain the assumptions behind the P/E ratio

Simply Wall St -

With An ROE Of 3.59%, Can Omaxe Limited (NSE:OMAXE) Catch Up To The Industry?

Return on Equity = Net Profit ÷ Shareholders Equity ROE is assessed against cost of equity, which is measured using the Capital Asset Pricing Model (CAPM) – but let’s not dive into the details of that today. … ROE can be dissected into three distinct ratios: net profit margin, asset turnover, and financial leverage. … This is called the Dupont Formula: Dupont Formula ROE = profit margin × asset turnover × financial leverage ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity) ROE = annual net profit ÷ shareholders’ equity NSEI:OMAXE Last Perf May 21st 18 The first component is profit margin, which measures how much of sales is retained after the company pays for all its expenses.

Simply Wall St -

OMAXE Company Info

Description

Omaxe Limited operates as a real estate development company in India. The company develops and sells integrated and hi-tech townships, group housing projects, shopping malls, office spaces, shop-cum-offices, hotel, and entertainment zones. The company was formerly known as Omaxe Construction Limited and changed its name to Omaxe Limited in June 2006. Omaxe Limited was founded in 1987 and is based in New Delhi, India. Omaxe Limited is a subsidiary of Guild Builders Private Limited.

Details
Name: Omaxe Limited
OMAXE
Exchange: NSEI
Founded: 1987
₹38,463,983,562
182,900,540
Website: http://www.omaxe.com
Address: Omaxe Limited
Omaxe House,
7, Local Shopping Centre,
New Delhi,
Delhi, 110019,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 532880 Equity Shares Mumbai Stock Exchange IN INR 09. Aug 2007
NSEI OMAXE Equity Shares National Stock Exchange of India IN INR 09. Aug 2007
Number of employees
Current staff
Staff numbers
0
Omaxe employees.
Industry
Real Estate Development
Real Estate
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 12:49
End of day share price update: 2019/04/24 00:00
Last earnings filing: 2019/02/12
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.